Skip to content

An adipocyte-driven mechanism for weight regain after weight loss: the yo-yo effect

An adipocyte-driven mechanism for weight regain after weight loss: the yo-yo effect - ADIPOSTRESS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37833
Enrollment
58
Registered
2012-02-15
Start date
2012-02-15
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adiposity obesity

Interventions

Subjects will receive meal replacements, replacing either all or part of the daily meals, during the intervention period. The first group will consume a 500 kcal/d diet for 5 weeks while the second

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy volunteers aged 20-65 y, BMI 28-35 kg/m2, non-smokers

Exclusion criteria

Exclusion criteria: Subjects using prescription medication, or suffering from diseases or conditions that might influence the outcome of the study: this concerns diseases/medication that influence body weight regulation (malabsorption, untreated hypo/hyperthyroidism, eating disorders, systemic use of steroids, etc.) and obesity-related cardiovascular risk factors (heart disease, systolic and diastolic blood pressures > 160/100 mmHg, blood glucose > 6.1 mmol L-1, blood cholesterol > 7 mmol L-1, blood triglycerides > 3 mmol L-1), marked alcohol consumption > 21 alcoholic units week-1 (male), or >14 alcoholic units week-1 (female), planned major changes in physical activity during the study to an extent that might interfere with the study outcome, as judged by the investigator; blood donation within the past 2 months prior to the study; weight change of >3 kg within 2 months prior to the study; psychiatric disease (based on medical history only); pregnant or lactating women, or women planning to become pregnant within the next 12 months; surgically treated obesity; participation in other clinical studies within the last 3 months; drug abuse (based on clinical judgment); unable to give informed consent; unable to engage in a low-calorie diet; following a special diet (e.g. Atkins).

Design outcomes

Primary

MeasureTime frame
The association between the amount of weight regain after the weight loss period and changes in adipokines, parameters of adipocyte metabolism, in vivo adipose tissue metabolism, adipocyte extracellular matrix gene expression profiles, adipocyte stress protein expression and gene polymorphisms in selected genes.

Secondary

MeasureTime frame
The difference in weight regain and associated parameters between rapid and slow weight loss regimens.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)